ACRS Aclaris Therapeutics has 3 clinical trials releasing topline data this year and sufficient cash to fund their operations through the end of 2025.
ACRS is in Piper Sandler`s potential 12 biotech takeovers in 2023.
ACRS reached 52 week low today: $5.05.
Analysts Price Targets:
$21 The Goldman Sachs Group
$29 BTIG Research
$38 Cantor Fitzgerald
$43 HC...
Expecting a move down to create what sort of resembles an inverted H&S lacking the left shoulder
If you look at the overall pattern its evident its in a down channel
A touch on the diagonal dotted line would be good.
IMO Aclaris Therapeutics Inc. stock can go up to $16.55 and I am bullish on it.
My trade levels are:
Entry level: $14.05
Take profit: $16.55
Stop loss: $13.45
Risk/reward: 4.17
This is the third time the stock is trying to break down the major support and to close the gap down
Looking at MAs and indicators, the stock is weak enough to consider to go short
Target is at 7.00 area
Price reverses into potential buy area of 20's. If drops, look for a long into 18's. Unlikely to go down to 16's again. Play with supporting good news.
BREAKOUT STOCK SELL ALERT
$ACRS - Aclaris Therapeutics, Inc. - Common Stock
Initial Alert Price: $3.46
Price High: $19.80
% Gains/Losses: 472.25%
(+450% More Than Expected)
ACRS topped out at $19.80 in Today's Trading Session providing a 454% Return on our Initial Trade Alert from Dec. 1st when the stock once only $3.46. This comes after the company announced...
BREAKOUT STOCK ALERT UPDATE
$ACRS - Aclaris Therapeutics, Inc. - Common Stock
Initial Alert Price: $3.46
Price High: $7.95
% Gains/Losses: 129.77%
(+107.77% More Than Expected)
Potential Stop Loss: $7.55
ACRS hit $7.95 in this morning's Premarket Session hitting a 52-Week High. The stock is currently consolidating from the run it's been on since Dec. 11th, so we...
BREAKOUT STOCK ALERT UPDATE
$ACRS - Aclaris Therapeutics, Inc. - Common Stock
Initial Alert Price: $3.46
Price High: $7.09
% Gains/Losses: 104.91%
(+82.91% More Than Expected)
Potential Stop Loss: $6.74
ACRS just cleared 104.91% on our initial trade alert in today's trading session. We would suggest selling half of positions here, and placing a trailing stop...
BREAKOUT STOCK ALERT UPDATE
$ACRS - Aclaris Therapeutics, Inc. - Common Stock
Initial Alert Price: $3.46
Price High: $6.60
% Gains/Losses: 90.75%
(90.53% More Than Expected)
Stop Loss Limit: $6.27
ACRS is currently completing consolidation from it's most recent Oct. 12th 5.02 breakout after announcing beginning of Phase 2a Clinical Trials. The stock has some...
BREAKOUT STOCK ALERT UPDATE
$ACRS - Aclaris Therapeutics, Inc. - Common Stock
Initial Alert Price: $3.46
Price High: $4.18
% Gains/Losses: 20.81%
(20.59% More Than Expected)
Stop Loss Limit: $3.97
ACRS is currently completing consolidation from it's most recent Oct. 12th 5.02 breakout after announcing beginning of Phase 2a Clinical Trials. The stock has some...
If the price breaks up in to the gap channel and hold support above $2.90 - $3.00. this could be swing trade with a price target of $4.40 ish a 40% + gain. with a stop loss of a break of the gap channel give your self some room but not to much on the stop stick to the stop and this could play out nicly as is is giving bullish sings by bouncing of the 50 moving...
I think that ACRS as it stands is a Covid19 play and could be the next CAPR with its drug discovery targets. Positive sentiment will keeping coming up. I also think that CLPS as an IT company will still have some positive sentiment and support correlations, at least on Monday. If I were you, I would likely be long pre or open market hours entry. That being said,...
